Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Recurrence 2Carcinoma, Non-Small-Cell Lung 2Neoplasm Metastasis 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, Follicular 1Lymphoma 1Leiomyosarcoma 1Hodgkin Disease 1

Interventions

Doxorubicin 6pazopanib 5Gemcitabine 4pembrolizumab 3Trabectedin 3Sorafenib 3Docetaxel 3Dacarbazine 3eribulin 2Sunitinib 2Radiotherapy, Conformal 2Radiotherapy 2Nivolumab 2Letrozole 2Ifosfamide 2Bevacizumab 2tremelimumab 1temsirolimus 1saracatinib 1sapanisertib 1rucaparib 1romidepsin 1olaratumab 1mocetinostat 1liposomal doxorubicin 1lenvatinib 1indolepropanol phosphate 1durvalumab 1cixutumumab 1cabozantinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Leiomyosarcoma × mocetinostat × Clear all
NCT02303262 2019-01-29

SARC018: A Study of Mocetinostat and Gemcitabine in Patients With Metastatic Leiomyosarcoma

Sarcoma Alliance for Research through Collaboration

Phase 2 Completed
20 enrolled 11 charts
Sarcoma

Leiomyosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡